Director of HIV Services
Department of HIV and Genitourinary Medicine
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom
Anton L. Pozniak, MD, FRCP, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV; fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speaker bureaus) from Gilead Sciences; and funds for research support from Gilead Sciences, Janssen, Merck, and ViiV.
Research Director (HIV and Infectious Diseases)
Hospital La Paz. IdiPAZ.
José R. Arribas, MD, has disclosed that he has received consulting fees from Gilead Sciences and Merck and fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speaker bureaus) from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Sharp and Dohme, and ViiV.
Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Daniel R. Kuritzkes, MD, has disclosed that he has received consulting fees from Gilead Sciences, Janssen, Merck, and ViiV; fees for non-CME/CE services from Gilead Sciences; and funds for research support from Gilead Sciences.
Consultant Genitourinary Physician
St James Hospital
Department of Medicine
Fiona Mulcahy, MD, FRCPI, has disclosed that she has received consulting fees from Gilead Sciences.
Executive Vice President
Edward King, MA, has no real or apparent conflicts of interest to report.
Megan K. Murphy, PhD, has real or apparent conflicts of interest to report.
Anna Poppa has no real or apparent conflicts of interest to report.
Editorial Director, Virology & Other Therapeutic Areas
Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This activity is intended for physicians, registered nurses, and other healthcare providers caring for patients with HIV infection.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.1 contact hours may be earned for successful completion of this activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 06, 2017, through January 05, 2018:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.
Watch an HIV expert panel discuss managing HCV infection in MSM, prescribing HIV PrEP to a PWID, and managing CVD in an HIV-infected woman.
CME-certified expert panel discussion on initiating or switching ART in a series of challenging patient cases.
In this downloadable slideset, Frederick L. Altice, MD, reviews the HIV treater’s role at the intersection of HIV infection, HCV infection, and the opioid crisis.
Listen to downloadable audio from a series of live Webinars by Paul E. Sax, MD, and Brian Wood, MD, in which the use of recently approved integrase inhibitor–based regimens is discussed and audience questions on this subject are addressed.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.